These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36564743)

  • 21. Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: Using evidence in the context of clinical practice.
    Bonifati C; Pansini F; Torres DD; Navaneethan SD; Craig JC; Strippoli GF
    Int J Artif Organs; 2006 Jan; 29(1):41-9. PubMed ID: 16485238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Incidence of peritonitis and catheter exit site infection in children undergoing automatic continuous cyclic peritoneal dialysis].
    Baciulis V; Jankauskiene A; Cerkauskiene R
    Medicina (Kaunas); 2003; 39 Suppl 1():70-4. PubMed ID: 12761424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.
    Johnson DW; Clark C; Isbel NM; Hawley CM; Beller E; Cass A; de Zoysa J; McTaggart S; Playford G; Rosser B; Thompson C; Snelling P;
    Perit Dial Int; 2009; 29(3):303-9. PubMed ID: 19458303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
    Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
    Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
    Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study.
    Pommer W; Brauner M; Westphale HJ; Brunkhorst R; Krämer R; Bundschu D; Höffken B; Steinhauer HB; Schümann E; Lüttgen FM; Schillinger-Pokorny E; Schaefer F; Wende R; Offner G; Näther S; Osten B; Zimmering M; Ehrich JH; Kehn M; Mansmann U; Grosse-Siestrup C
    Am J Kidney Dis; 1998 Nov; 32(5):752-60. PubMed ID: 9820444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between types of dressing following catheter insertion and early exit-site infection in peritoneal dialysis.
    Figueiredo AE; de Mattos C; Saraiva C; Olandoski M; Barretti P; Pecoits Filho R; de Moraes TP;
    J Clin Nurs; 2017 Nov; 26(21-22):3658-3663. PubMed ID: 28122398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients.
    Casey M; Taylor J; Clinard P; Graham A; Mauck V; Spainhour L; Brown P; Burkart J
    Perit Dial Int; 2000; 20(5):566-8. PubMed ID: 11117248
    [No Abstract]   [Full Text] [Related]  

  • 30. 32 years' experience of peritoneal dialysis-related peritonitis in a university hospital.
    van Esch S; Krediet RT; Struijk DG
    Perit Dial Int; 2014; 34(2):162-70. PubMed ID: 24584620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology, management, and prevention of exit site infections in peritoneal dialysis patients.
    Sachar M; Shah A
    Ther Apher Dial; 2022 Apr; 26(2):275-287. PubMed ID: 34435734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of topical mupirocin and gentamicin in the prevention of peritoneal dialysis-related infections: A systematic review and meta-analysis.
    Tsai CC; Yang PS; Liu CL; Wu CJ; Hsu YC; Cheng SP
    Am J Surg; 2018 Jan; 215(1):179-185. PubMed ID: 28341139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis.
    Rodríguez-Carmona A; Pérez-Fontán M; López-Muñiz A; Ferreiro-Hermida T; García-Falcón T
    Perit Dial Int; 2014; 34(6):618-26. PubMed ID: 23818005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of topical mupirocin on peritoneal dialysis infection rates in Singapore General Hospital.
    Lim CT; Wong KS; Foo MW
    Nephrol Dial Transplant; 2005 Aug; 20(8):1702-6. PubMed ID: 15855200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years.
    Lobbedez T; Gardam M; Dedier H; Burdzy D; Chu M; Izatt S; Bargman JM; Jassal SV; Vas S; Brunton J; Oreopoulos DG
    Nephrol Dial Transplant; 2004 Dec; 19(12):3140-3. PubMed ID: 15466881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorhexidine for routine PD catheter exit-site care.
    Olga B; Fotis Z; Margarita I; Sofia X; Konstantinos S
    Int Urol Nephrol; 2016 Sep; 48(9):1543-6. PubMed ID: 27432412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ["Naked" exit-site for peritoneal dialysis catheters].
    Previti A; Savi U; Lentini P; Bandera A
    G Ital Nefrol; 2022 Feb; 39(1):. PubMed ID: 35191628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dialysis: The importance of peritoneal catheter exit-site care.
    Piraino B
    Nat Rev Nephrol; 2010 May; 6(5):259-60. PubMed ID: 20424630
    [No Abstract]   [Full Text] [Related]  

  • 39. Association between keeping home records of catheter exit-site and incidence of peritoneal dialysis-related infections.
    Iida H; Kurita N; Fujimoto S; Kamijo Y; Ishibashi Y; Fukuma S; Fukuhara S
    Int Urol Nephrol; 2018 Apr; 50(4):763-769. PubMed ID: 29349637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful use of sodium hypochlorite pack plus systemic and local antibiotic therapy for the treatment of pseudomonas infection of peritoneal dialysis catheter exit-site.
    Rodighiero MP; Dell'Aquila R; Bonello M; Spanò E; Loreto PD; Nalesso F; Ronco C
    Contrib Nephrol; 2007; 154():125-128. PubMed ID: 17099307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.